| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 23rd, 2004 | 15 | Yes |
Popular Name: 1-Phenyl-1H-benzoimidazole 1-Phenyl-1H-benzoimidazole
Find On: PubMed — Wikipedia — Google
CAS Numbers: 2622-60-8 , 97542-80-8 , [2622-60-8] , [97542-80-8]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.77 | 9.15 | -8.04 | 0 | 2 | 0 | 18 | 194.237 | 1 | ↓ |
| Lo Low (pH 4.5-6) | 2.77 | 9.63 | -29.25 | 1 | 2 | 1 | 19 | 195.245 | 1 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Purity | 95% | Matrix Scientific |
| PUBCHEM_PATENT_ID | EP0126231A2; EP0888344A1; US4508892; US4533678; US4615986; US6110903; WO1997033887A1; WO1998039343A1; WO2000015845A1 | IBM Patent Data |
| Warnings | IRRITANT | Matrix Scientific |
| Warnings | Irritant/Refrigerate | Matrix Scientific |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9300 | 0.47 | Binding ≤ 10μM |
| PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2300 | 0.53 | Functional ≤ 10μM |
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2300 | 0.53 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PGFRB_MOUSE | P05622 | Platelet-derived Growth Factor Receptor Beta, Mouse | 9300 | 0.47 | Binding ≤ 10μM |
| PGFRA_RAT | P20786 | Platelet-derived Growth Factor Receptor Alpha, Rat | 2300 | 0.53 | Functional ≤ 10μM |
| PGFRB_RAT | Q05030 | Platelet-derived Growth Factor Receptor Beta, Rat | 2300 | 0.53 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Constitutive PI3K/AKT Signaling in Cancer | |
| Downstream signal transduction | |
| PIP3 activates AKT signaling | |
| Signaling by PDGF |